Prognostic value of tumour-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment

The multidisciplinary treatment including induction chemotherapy plus conversion surgery (CS) has attracted attention as a new strategy to improve the outcome of metastatic gastric cancer (MGC). However, it is unclear which patients achieve a good response to chemotherapy and successful CS.